Zurcher Kantonalbank (Zurich Cantonalbank) - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 121 filers reported holding C4 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$18,843
-6.6%
6,001
+75.4%
0.00%
Q4 2022$20,184
-32.7%
3,4210.0%0.00%
Q3 2022$30,000
+15.4%
3,4210.0%0.00%
Q2 2022$26,000
-68.7%
3,4210.0%0.00%
Q1 2022$83,000
-24.5%
3,4210.0%0.00%
-100.0%
Q4 2021$110,0003,4210.00%
Other shareholders
C4 THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,642,210$39,840,0003.87%
Paradigm Biocapital Advisors LP 499,496$12,118,0003.20%
Cypress Point Wealth Management, LLC 118,573$2,877,0002.92%
COMMODORE CAPITAL LP 481,094$11,671,0002.61%
Nextech Invest Ltd. 375,857$9,118,0002.60%
RTW INVESTMENTS, LP 4,531,982$109,946,0002.28%
SPHERA FUNDS MANAGEMENT LTD. 362,528$8,795,0001.24%
Perceptive Advisors 2,082,723$50,526,0001.01%
CLOUGH CAPITAL PARTNERS L P 356,181$8,641,0000.66%
HighVista Strategies LLC 34,760$843,0000.54%
View complete list of C4 THERAPEUTICS INC shareholders